PTC announces FDA acceptance, priority review of NDA for vatiquinone
PTC Therapeutics (PTCT) announced that the U.S. Food and Drug Administration, FDA, has accepted for filing the New Drug Application, NDA, for ...
Hosted on MSN54m
Filler Is Dead—Long Live Filler
No wonder undergoing regular filler appointments has become as commonplace as your biannual dentist visit. At least, until recently. Our faces, on full display, have become something of a battleground ...